Calidi Biotherapeutics (CLDI) Debt Ratio (2022 - 2025)
Calidi Biotherapeutics' quarterly Debt Ratio came in at 0.02 in Q4 2025, up 43.61% year-on-year from 0.02 in Q4 2024, and up 5.6% quarter-over-quarter from 0.02 in Q3 2025.
Calidi Biotherapeutics has reported Debt Ratio for 4 years, with the latest figure at 0.02 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio rose 43.61% year-over-year to 0.02; the trailing twelve-month figure through Dec 2025 stood at 0.02 (up 43.61% YoY), and the FY2025 full-year result was 0.02, up 43.61% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.02, up from 0.02 in the prior quarter.
- The five-year high for Debt Ratio was 53.47 in Q2 2025, with the low at 0.0 in Q1 2023.
- Average Debt Ratio over 4 years is 4.53, with a median of 0.03 recorded in 2024.
- Year-over-year, Debt Ratio plunged 92.35% in 2024 and surged 162870.13% in 2025.
- Tracing CLDI's Debt Ratio over 4 years: stood at 0.39 in 2022, then tumbled by 46.6% to 0.21 in 2023, then sank by 92.35% to 0.02 in 2024, then jumped by 43.61% to 0.02 in 2025.
- The last three Debt Ratio figures came in at 0.02 (Q4 2025), 0.02 (Q3 2025), and 53.47 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 0.05 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Calidi Biotherapeutics | - | - | - | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 53.47 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.39 |